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Animal studies have revealed brain regions that control homeostatic feeding, but the rampant over-
eating contributing to the obesity epidemic suggests the participation of ‘‘nonhomeostatic’’ control
centers. Recent papers by Batterham et al. (2007) and Farooqi et al. (2007) link peptide YY3–36 and
leptin to the activation of nonhomeostatic brain regions.Since the discovery of leptin in 1994,
considerable progress has been
made, largely in rodent models, in
identifying energy status signals, the
locations of the relevant receptor-
bearing neurons, and the downstream
neurochemical systems and circuits
that control food intake. In these stud-
ies, the effects of treatments (e.g., ge-
netic or pharmacological manipulation
of receptors in targeted brain regions)
on feeding are compared to a basal
level of food intake. For humans and
even rodents, however, metabolic
need (negative energy balance) is not
the only motivation to consume food.
Other motivations to feed can be
traced to the rewarding features of
simultaneously available attractive
foods, temporal factors (time of day,
season), emotion, and cognition
(learning, memory, social cues). Col-
lectively, these factors influence ‘‘non-
homeostatic’’ food intake. Attention to
the neural underpinnings of nonho-
meostatic controls as distinct from ho-
meostatic control also derives from the
obesity epidemic itself and the aware-
ness that for many humans, overeating
is not kept in check by homeostatic
mechanisms.
Successes in describingmechanisms
and circuits underlying homeostatic
controls are beginning to generate
experiments to more fully understand
the control of human feeding. Among
these ideas are that (1) different brain
systems may mediate distinct motiva-
tions to feed, (2) signals considered
relevant to theneural control of homeo-
staticmotivationmayalso impact upon
neural circuitries associated with non-
homeostatic control systems, and (3)
activation of nonhomeostatic neuralsystems may override controls on
feeding originating from homeostatic
systems. At the same time, however,
a healthy skepticism is required in ap-
plying functional descriptors to brain
regions, as individual brain regions
may well contribute to homeostatic as
well as nonhomeostatic control func-
tions (see Figure 1). The application to
humans of noninvasive methods that
highlight the contributions of specific
brain areas to the control of human
feeding and drug addiction is drawing
attention to brain regions increasingly
associated with nonhomeostatic con-
trol. Recent papers by Batterham
et al. (2007) and Farooqi et al. (2007)
use functional magnetic resonance
imaging (fMRI) to examine whether
the activity of brain regions associated
with homeostatic and nonhomeostatic
control of feeding is affected by treat-
ment with the gut peptide PYY3–36 or
leptin, which reduce food intake in
humans and animals.
Batterham et al. (2007) report that
manipulation of PYY3–36 levels results
in significant activation of brain regions
relevant to homeostatic control (para-
brachial nucleus, hypothalamus) and
areas associated with both homeo-
static and nonhomeostatic control,
regions related to food reward (ventral
tegmental area, ventral striatum, orbi-
tofrontal cortex [OFC]), and other re-
gions related to taste, visceral sen-
sation, food imagery, and memory
(insular cortex). At the same analysis
threshold, no increased activation
was observed in the nucleus of the
solitary tract, the region activated by
the vagal afferents that transmit PYY
signals from the gut to brain, or in the
nucleus accumbens (NAc), a regionCell Metabolism 6, Dadjacent to the ventral striatum that is
associated with food and drug reward.
A correlation between the magnitude
of activation of theOFC (the area show-
ing greatest treatment-induced activity)
by PYY3–36 treatment and the reduction
in food intake on the PYY3–36 treat-
ment day suggests a contribution of
this brain area to the feeding effect of
PYY3–36.
A parallel approach is taken in
another recent fMRI study by Farooqi
et al. (2007). They examined the ef-
fects of another food-intake-reducing
hormone, leptin, on brain activation eli-
cited by food images in congenital lep-
tin-deficient and in normal control sub-
jects. In the leptin-deficient state,
activation of the anterior medial ventral
striatum correlated positively with sub-
jects’ ratings of likability of presented
food images, but leptin treatment elim-
inated this positive correlation. The au-
thors conclude that leptin acts to mod-
ulate human feeding via actions on
neural circuits, including those in the
ventral striatum, to increasediscrimina-
tion of the rewarding properties of food.
These studies highlight the activa-
tion of regions of the brain associated
with food reward and nonhomeostatic
control by meal-related (PYY3–36) and
energy availability (leptin) signals.
Together, these findings are important
as they nudge the field to expand its
neural perspective of food intake con-
trol beyond the hypothalamus (see
Grill and Kaplan, 2002; Berthoud,
2007). A more complete understand-
ing of the neural underpinnings of
human feeding is an enterprise that
will require the integration of findings
from noninvasive techniques in humans
and from invasive and reductionistecember 2007 ª2007 Elsevier Inc. 423
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new work will benefit from larger sub-
ject pools, attention to individual differ-
ences, and the application of new
combined methods and behavioral
paradigms. The small number of sub-
jects examined in these two recent
fMRI studies limits the types of analy-
ses (whole brain versus region of inter-
est), the power of the analyses to
reveal meaningful data, and the poten-
tial value that individual subject differ-
ence can bring to the interpretation of
brain activation patterns. Recent stud-
ies by Cornier et al. exploited individual
subject differences in their designs.
Thin, obesity-resistant subjects (Corn-
ier et al., 2007) and reduced-weight,
obesity-prone subjects (M.A. Cornier,
personal communication) were exam-
ined for effects of eucaloric mainte-
nance and overfeeding on fMRI re-424 Cell Metabolism 6, December 2007 ªsponses to food images. Overfeeding
significantly attenuated brain activa-
tion in visual cortical areas and the hy-
pothalamus elicited by hedonically
positive food images in the eucaloric
state. Interestingly, the effect of
overfeeding on brain activation pat-
terns was observed in the thin, obe-
sity-resistant subjects but not in the
obesity-prone subjects, suggesting
that the positive energy balance (over-
feeding) signals that operate to reduce
food reward and thereby food intake in
lean subjects are absent or overridden
in obesity-prone subjects.
The Batterham et al. (2007) and
Farooqi et al. (2007) studies do not
consider the relationship between the
activation of structures labeled as non-
homeostatic and those considered
relevant to homeostatic controls on
human feeding (Berthoud, 2007). The2007 Elsevier Inc.same, however, can be said about the
animal research literature that is also
in its infancy in interpreting the relative
roles of reward-related and homeosta-
sis-related brain regions in mediating
food intake effects of leptin or ghrelin
treatment (Hommel et al., 2006; Fulton
et al., 2006; Naleid et al., 2005). While
some animal studies do address the
idea that brain regions associated
with learning can override the controls
on feeding exerted by regions mediat-
ing homeostatic controls (e.g., Petro-
vich et al., 2002), more emphasis on
animal work addressing this and other
aforementioned ideas will be critical in
interpreting the current and future
fMRI results. Also useful in interpreting
future human brain imaging studieswill
be the application of methods that
combine brain imaging with radioli-
gand binding to enable region-specific
assessments of neurotransmitter re-
lease and neuronal activation. For
example, using [11C]raclopride (a dopa-
mine D2 receptor radioligand sensitive
to competition with endogenous dopa-
mine), Volkow et al. (2006) showed that
dopamine is released in the dorsal but
not the ventral striatum of cocaine ad-
dicts viewing cocaine cue videos dur-
ing imaging, implicating the substantia
nigra as the dopamine source.
The Batterham et al. (2007) and
Farooqi et al. (2007) studies implicate
the OFC and ventral striatum in the
control of human food intake. These
areas contribute to many behavioral
systems, but their roles in the control
of food reward and in mediating the
effects of PYY and leptin on feeding
via adjustments in food reward are
highlighted in these studies. Detailed
examinations of the functional ele-
ments and subregional distinctions of
these ‘‘nonhomeostatic’’ brain regions
involved in the control of intake are
needed. Careful consideration must
also be given to the notion that these
forebrain regions affect intake control
via input to and mediation by hypotha-
lamic and hindbrain regions that em-
body ‘‘homeostatic’’ control of intake.
Research on the neural systems that
mediate the control of food intake and
thereby contribute to hyperphagia and
obesity began with a focus on the
control of feeding inducedbymetabolic
need—so-called homeostatic controls.Figure 1. Brain Regions Associated with Homeostatic and Nonhomeostatic Control
Structures traditionally considered as homeostatic mediators of energy balance control (blue
boxes) and other structures associated with nonhomeostatic control (yellow boxes) are high-
lighted. Receptors and significant enzymatic activities for well-characterized meal- or adiposity-
related correlates relevant to homeostatic function are listed in the brain structures in which
they are expressed. It is clear from the widespread expression of these receptors and enzymes
that structures referred to as nonhomeostatic receive input from many of the same energy status
signals as structures traditionally labeled as homeostatic. The interconnections between struc-
tures (designated by arrows) emphasize that traditionally defined ‘‘nonhomeostatic’’ regions of
the brain also receive input from and relay input to brain regions involved in homeostatic control,
further blurring the distinction between these functional descriptors as applied to specific regions
of the brain. The expression pattern for the energy status signals is taken from the rodent literature,
as data for the human brain are more limited. Abbreviations: NTS, nucleus tractus solitarius; PBN,
parabrachial nucleus; VTA, ventral tegmental area; SN, substantia nigra; NAc, nucleus accum-
bens; Cx, cortex; PFC, prefrontal cortex; OFC, orbitofrontal cortex; ObRb, functional leptin recep-
tor; GHSR, ghrelin receptor; Y2R, Y-2 receptor; MC3/MC4R, melanocortin 3 and 4 receptors; GK,
glucokinase activity; GLP-1R, glucagon-like peptide-1 receptor.
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PreviewsRecent studies highlight other, nonho-
meostatic controls of feeding related
to food reward and learning. The ques-
tion is whether the regions highlighted
in these studies should be considered
as functionally apart from or interacting
with homeostatic controls.
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a negligible role of the lysosomal sys-
tem in this adaptation. Nonetheless,
differential display analyses initially
led to the identification of cathepsin
L mRNA as being overexpressed in
atrophyingmuscles fromseptic and tu-
mor-bearing rats (Deval et al., 2001).
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tially expressed in various models of
muscle atrophy (Lecker et al., 2004).
Atrogenes encompass the ubiquitin li-
gases MAFbx/atrogin-1 and MuRF1,
which seemcritical in ubiquitin-protea-
some proteolysis, and also cathepsin L
and proteins important for autophagy.
While cathepsins determine the pro-
teolytic capacity of lysosomes, au-
tophagy is required to drive substrates
to lysosomes, and additional observa-
tions have emphasized the importance
of this process in muscle. First, au-
tophagy does occur in cultured myo-
tubes and is critical for the amino
acid-dependent regulation of proteol-
ysis (Mordier et al., 2000). Second,
there is direct evidence for impaired ly-
sosomal function and autophagy in
various myopathies (Bechet et al.,
2005). Third, to investigate autophagy
in vivo, Mizushima et al. (2004) gener-
ated transgenic mice expressing the
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